An accurate new blood test for colon cancer, the fourth leading cause of cancer deaths in the US, has been reported.

A new DNA test developed in the UK can accurately predict whether high-risk patients will develop colorectal cancer in the ...

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...

About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.

People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for ...

A simple blood test has shown promising results in accurately detecting colon cancer, a deadly disease that is rising at an ...

A recent American Cancer Society report highlights the increasing incidence of colorectal cancer in young adults. Understanding risk factors and recognizing symptoms are crucial for early detection ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

An investigational blood test can detect colorectal cancer (CRC) in patients at average risk of CRC, a study suggests.

Researchers sought to determine trends and future patterns for liver, pancreatic, colorectal, stomach, and esophageal cancers in the US.

The study, funded by Cancer Research UK, could lead to a blood test which will inform doctors which inflammatory bowel ...